ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000260641.1	Gefitinib	Cervical squamouscell carcinoma and endocervical adenocarcinoma	0.016903184	Resistant
ENSG00000260641.1	Gefitinib	Pancreatic adenocarcinoma	0.029681274	Sensitive